News
-
-
PRESS RELEASE
EQS-Adhoc: aap Implantate AG: Company EBITDA for fiscal year 2024 at EUR –0.85 million; postponement of publication of consolidated financial statements
aap Implantate AG reports Company EBITDA of EUR -0.85 million for fiscal year 2024, leading to the postponement of consolidated financial statements publication. Analysts review impact -
-
PRESS RELEASE
aap makes a stable start to financial year 2025 - growth in the region with the highest sales EMEA region
aap Implantate AG reports stable business development in Q1 2025, with significant sales growth in the EMEA region and successful new product placements. The company anticipates further growth in Q2 -
-
PRESS RELEASE
EQS-Adhoc: aap Implantate AG: Postponement of the publication of the annual financial statements and consolidated financial statements for the financial year 2024
aap Implantate AG postpones the publication of its 2024 annual and consolidated financial statements due to auditor delay and resource constraints. New deadline set for June 2025 -
-
-
-